Skip to main content

Table 5 Sensitivity analysis (average monthly total costs: JPY)

From: Real-world cost analysis of chemotherapy for colorectal cancer in Japan: detailed costs of various regimens during the entire course of chemotherapy

 

Oxaliplatin-based regimens

Irinotecan-based regimens

Regimens including molecular targeted agents

(n = 13)

(n = 31)

(n = 11)

Base-case

418,463

215,499

705,460

Hospitalization

390,487

223,597

690,343

Outpatient

327,177

160,287

627,033

Imaging Max

433,991

215,499

720,541

Imaging Min

418,463

199,972

705,013

Brand drug

418,463

215,888

707,715

Generic drug

404,097

214,046

694,883

  1. Hospitalization = in the scenario of 3 days’ hospitalization; Outpatient = in the scenario of outpatient visit; Imaging Max = in the scenario of maximum utilization of diagnostic imaging tests; Imaging Min = in the scenario of minimum utilization of diagnostic imaging tests; Brand drug = in the scenario of using brand leucovorin; Generic drug = in the scenario of using generic leucovorin